Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 24-Apr-24 4:30 PM View:  | Brightstar Associates LLC 10% Owner | Deciphera Pharmaceuticals, ... (DCPH) | 22-Apr-24 | Exercise (in-the money or at-the-money) | 48,136 | $0.01 | $481.36 | < 1% 23.06M to 23.11M | |
| 20-Feb-24 4:06 PM View: | Sherman Matthew L EVP & Chief Medical Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Feb-24 | Sale | 2,615 | $15.62 | $40,840.30 | (2%) 111.35K to 108.74K | |
| 20-Feb-24 4:05 PM View: | Kelly Thomas Patrick Chief Financial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Feb-24 | Sale | 3,010 | $15.62 | $47,009.30 | (4%) 83.36K to 80.35K | |
| 20-Feb-24 4:05 PM View: | Pitman Jama SVP, Chief Development Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Feb-24 | Sale | 2,267 | $15.62 | $35,405.10 | (3%) 70.3K to 68.03K | |
| 20-Feb-24 4:05 PM View: | Martin Daniel C. Chief Commercial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Feb-24 | Sale | 2,267 | $15.62 | $35,405.10 | (4%) 57.38K to 55.12K | |
| 20-Feb-24 4:05 PM View: | Kelly Thomas Patrick Chief Financial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 15-Feb-24 | Grant | 17,275 | -- | -- | 26% 66.08K to 83.36K | |
| 20-Feb-24 4:05 PM View: | Pitman Jama SVP, Chief Development Officer | Deciphera Pharmaceuticals, ... (DCPH) | 15-Feb-24 | Grant | 19,725 | -- | -- | 39% 50.57K to 70.3K | |
| 20-Feb-24 4:05 PM View: | Martin Daniel C. Chief Commercial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 15-Feb-24 | Grant | 9,725 | -- | -- | 20% 47.66K to 57.38K | |
| 20-Feb-24 4:06 PM View: | Sherman Matthew L EVP & Chief Medical Officer | Deciphera Pharmaceuticals, ... (DCPH) | 15-Feb-24 | Grant | 17,275 | -- | -- | 18% 94.08K to 111.35K | |
| 20-Feb-24 4:05 PM View: | Dhanak Dashyant EVP & Chief Scientific Officer | Deciphera Pharmaceuticals, ... (DCPH) | 15-Feb-24 | Grant | 17,275 | -- | -- | 12% 140.9K to 158.18K | |
| 09-Feb-24 4:30 PM View: | Brightstar Associates LLC 10% Owner | Deciphera Pharmaceuticals, ... (DCPH) | 07-Feb-24 | Exercise (in-the money or at-the-money) | 914,001 | $0.01 | $9,140.01 | 4% 22.15M to 23.06M | |
| 18-Jan-24 4:15 PM View: | Pitman Jama SVP, Chief Development Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Jan-24 | Private Sale | 1,624 | $14.47 | $23,499.00 | (3%) 52.2K to 50.57K | |
| 18-Jan-24 4:15 PM View: | Martin Daniel C. Chief Commercial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Jan-24 | Private Sale | 1,624 | $14.47 | $23,498.80 | (3%) 49.28K to 47.66K | |
| 18-Jan-24 4:15 PM View: | Sherman Matthew L EVP & Chief Medical Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Jan-24 | Private Sale | 2,435 | $14.47 | $35,233.70 | (3%) 96.51K to 94.08K | |
| 18-Jan-24 4:15 PM View: | Kelly Thomas Patrick Chief Financial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Jan-24 | Private Sale | 2,435 | $14.47 | $35,234.00 | (4%) 68.52K to 66.08K | |
| 14-Dec-23 4:05 PM View: | Sherman Matthew L EVP & Chief Medical Officer | Deciphera Pharmaceuticals, ... (DCPH) | 13-Dec-23 | Sale | 2,792 | $15.37 | $42,904.90 | (3%) 99.31K to 96.51K | |
| 14-Dec-23 4:05 PM View: | Pitman Jama See Remarks | Deciphera Pharmaceuticals, ... (DCPH) | 13-Dec-23 | Sale | 1,662 | $15.37 | $25,540.10 | (3%) 53.86K to 52.2K | |
| 14-Dec-23 4:05 PM View: | Kelly Thomas Patrick Chief Financial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 13-Dec-23 | Sale | 2,792 | $15.37 | $42,904.90 | (4%) 71.31K to 68.52K | |
| 14-Dec-23 4:05 PM View: | Martin Daniel C. Chief Commercial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 13-Dec-23 | Sale | 1,727 | $15.37 | $26,539.00 | (3%) 51.01K to 49.28K | |
| 14-Dec-23 4:05 PM View: | Hoerter Steven L. President and CEO Director | Deciphera Pharmaceuticals, ... (DCPH) | 13-Dec-23 | Sale | 30,664 | $15.37 | $471,217.00 | (30%) 103.43K to 72.76K | |
| 14-Dec-23 4:05 PM View: | Hoerter Steven L. President and CEO Director | Deciphera Pharmaceuticals, ... (DCPH) | 12-Dec-23 | Grant | 62,500 | -- | -- | 153% 40.93K to 103.43K | |
| 14-Dec-23 4:05 PM View: | Sherman Matthew L EVP & Chief Medical Officer | Deciphera Pharmaceuticals, ... (DCPH) | 12-Dec-23 | Grant | 8,244 | -- | -- | 9% 91.06K to 99.31K | |
| 14-Dec-23 4:05 PM View: | Pitman Jama See Remarks | Deciphera Pharmaceuticals, ... (DCPH) | 12-Dec-23 | Grant | 5,576 | -- | -- | 12% 48.28K to 53.86K | |
| 14-Dec-23 4:05 PM View: | Kelly Thomas Patrick Chief Financial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 12-Dec-23 | Grant | 8,244 | -- | -- | 13% 63.07K to 71.31K | |
| 14-Dec-23 4:05 PM View: | Martin Daniel C. Chief Commercial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 12-Dec-23 | Grant | 5,576 | -- | -- | 12% 45.44K to 51.01K | |
| 01-Dec-23 4:05 PM View: | Martin Daniel C. Chief Commercial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 30-Nov-23 | Private Sale | 17,801 | $12.57 | $223,755.00 | (28%) 63.24K to 45.44K | |
| 31-Oct-23 4:10 PM View: | Martin Daniel C. Chief Commercial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 30-Oct-23 | Sale | 1,407 | $12.02 | $16,908.80 | (2%) 64.29K to 62.88K | |
| 31-Oct-23 4:09 PM View: | Hoerter Steven L. President and CEO Director | Deciphera Pharmaceuticals, ... (DCPH) | 30-Oct-23 | Sale | 21,573 | $12.02 | $259,256.00 | (35%) 62.5K to 40.93K | |
| 31-Oct-23 4:11 PM View: | Sherman Matthew L EVP & Chief Medical Officer | Deciphera Pharmaceuticals, ... (DCPH) | 30-Oct-23 | Sale | 2,360 | $12.02 | $28,361.50 | (3%) 92.99K to 90.63K | |
| 31-Oct-23 4:10 PM View: | Pitman Jama See Remarks | Deciphera Pharmaceuticals, ... (DCPH) | 30-Oct-23 | Sale | 1,407 | $12.02 | $16,908.80 | (3%) 49.69K to 48.28K | |
| 31-Oct-23 4:09 PM View: | Kelly Thomas Patrick Chief Financial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 30-Oct-23 | Sale | 2,316 | $12.02 | $27,832.80 | (4%) 65.38K to 63.07K | |
| 31-Oct-23 4:11 PM View: | Sherman Matthew L EVP & Chief Medical Officer | Deciphera Pharmaceuticals, ... (DCPH) | 28-Oct-23 | Grant | 8,244 | -- | -- | 10% 84.74K to 92.99K | |
| 31-Oct-23 4:10 PM View: | Pitman Jama See Remarks | Deciphera Pharmaceuticals, ... (DCPH) | 28-Oct-23 | Grant | 5,576 | -- | -- | 13% 44.11K to 49.69K | |
| 31-Oct-23 4:09 PM View: | Kelly Thomas Patrick Chief Financial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 28-Oct-23 | Grant | 8,244 | -- | -- | 14% 57.14K to 65.38K | |
| 31-Oct-23 4:10 PM View: | Martin Daniel C. Chief Commercial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 28-Oct-23 | Grant | 5,576 | -- | -- | 9% 58.72K to 64.29K | |
| 31-Oct-23 4:09 PM View: | Hoerter Steven L. President and CEO Director | Deciphera Pharmaceuticals, ... (DCPH) | 28-Oct-23 | Grant | 62,500 | -- | -- | 100% 0 to 62.5K | |
| 04-Oct-23 4:05 PM View: | Sherman Matthew L EVP & Chief Medical Officer | Deciphera Pharmaceuticals, ... (DCPH) | 02-Oct-23 | Private Sale | 2,942 | $12.68 | $37,304.60 | (3%) 87.69K to 84.74K | |
| 19-Sep-23 4:05 PM View: | Dhanak Dashyant EVP & Chief Scientific Officer | Deciphera Pharmaceuticals, ... (DCPH) | 15-Sep-23 | Grant | 140,900 | -- | -- | 100% 0 to 140.9K | |
| 21-Jun-23 4:05 PM View: | Flynn Daniel Lee Chief Scientific Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Jun-23 | Private Sale | 1,655 | $14.40 | $23,835.00 | (< 1%) 380.27K to 378.61K | |
| 21-Jun-23 4:05 PM View: | Martin Daniel C. Chief Commercial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Jun-23 | Private Sale | 1,238 | $14.40 | $17,829.40 | (2%) 59.65K to 58.41K | |
| 21-Jun-23 4:05 PM View: | Sherman Matthew L EVP & Chief Medical Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Jun-23 | Private Sale | 1,655 | $14.40 | $23,835.00 | (2%) 89.34K to 87.69K | |
| 21-Jun-23 4:05 PM View: | Pitman Jama See Remarks | Deciphera Pharmaceuticals, ... (DCPH) | 16-Jun-23 | Private Sale | 1,238 | $14.40 | $17,829.40 | (3%) 45.05K to 43.81K | |
| 21-Jun-23 4:05 PM View: | Kelly Thomas Patrick Chief Financial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Jun-23 | Private Sale | 1,655 | $14.40 | $23,835.00 | (3%) 58.8K to 57.14K | |
| 12-Jun-23 4:05 PM View: | Friedman Franklin Stuart Director | Deciphera Pharmaceuticals, ... (DCPH) | 08-Jun-23 | Purchase | 10,000 | $13.88 | $138,828.00 | 100% 0 to 10.0K | |
| 12-May-23 4:05 PM View: | Walsh Dennis Leo Director | Deciphera Pharmaceuticals, ... (DCPH) | 10-May-23 | Purchase | 11,000 | $13.86 | $152,416.00 | 100% 0 to 11.0K | |
| 23-Mar-23 4:05 PM View: | Hoerter Steven L. President and CEO Director | Deciphera Pharmaceuticals, ... (DCPH) | 21-Mar-23 | Private Sale (Planned) | 7,500 | $15.57 | $116,782.00 | (100%) 7.5K to 0 | |
| 01-Mar-23 4:15 PM View: | Brightstar Associates LLC 10% Owner | Deciphera Pharmaceuticals, ... (DCPH) | 28-Feb-23 | Exercise (in-the money or at-the-money) | 2,427,690 | $0.01 | $24,276.90 | 12% 19.72M to 22.15M | |
| 17-Feb-23 4:07 PM View: | Sherman Matthew L EVP & Chief Medical Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Feb-23 | Sale | 971 | $15.10 | $14,661.10 | (1%) 89.12K to 88.14K | |
| 17-Feb-23 4:14 PM View: | Pitman Jama See Remarks | Deciphera Pharmaceuticals, ... (DCPH) | 16-Feb-23 | Sale | 1,159 | $15.10 | $17,499.70 | (3%) 46.21K to 45.05K | |
| 17-Feb-23 4:09 PM View: | Kelly Thomas Patrick Chief Financial Officer | Deciphera Pharmaceuticals, ... (DCPH) | 16-Feb-23 | Sale | 1,370 | $15.10 | $20,685.60 | (2%) 60.16K to 58.8K |
